Sign up to save your podcasts
Or
Share Episode 420: ASCO 2025 - CheckMate 901: Ipi/Nivo vs chemo for Cis-ineligible metastatic urothelial cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 420: ASCO 2025 - CheckMate 901: Ipi/Nivo vs chemo for Cis-ineligible metastatic urothelial cancer
Michiel Van Der Heijden joins us to discuss the Ipi/Nivo vs chemo randomization in this trial from his ASCO 2025 presentation
View all episodes
By The Uromigos
4.9
5555 ratings
Michiel Van Der Heijden joins us to discuss the Ipi/Nivo vs chemo randomization in this trial from his ASCO 2025 presentation
More shows like The Uromigos
View all
JAMA Editors' Summary
135 Listeners
Prostate Cancer Update
14 Listeners
NEJM This Week
319 Listeners
JAMA Clinical Reviews
498 Listeners
AFP: American Family Physician Podcast
688 Listeners
ASCO Daily News
58 Listeners
White Coat Investor Podcast
2,422 Listeners
The Curbsiders Internal Medicine Podcast
3,326 Listeners
The Peter Attia Drive
7,999 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
517 Listeners
GU Cast | Urology Podcast
2 Listeners
BioCentury This Week
30 Listeners
Two Onc Docs
181 Listeners
The View on GU | with Lalani and Wallis
2 Listeners